Invesco Ltd. Has $13.45 Million Holdings in Olin Co. (NYSE:OLN)

Invesco Ltd. boosted its holdings in Olin Co. (NYSE:OLN - Free Report) by 19.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 398,057 shares of the specialty chemicals company's stock after purchasing an additional 64,449 shares during the period. Invesco Ltd. owned about 0.34% of Olin worth $13,454,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the business. Wilmington Savings Fund Society FSB boosted its stake in shares of Olin by 9.4% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 5,833 shares of the specialty chemicals company's stock valued at $197,000 after buying an additional 500 shares during the last quarter. Connable Office Inc. raised its holdings in Olin by 9.3% in the fourth quarter. Connable Office Inc. now owns 6,207 shares of the specialty chemicals company's stock valued at $210,000 after acquiring an additional 527 shares in the last quarter. First Citizens Bank & Trust Co. boosted its stake in Olin by 8.5% during the 4th quarter. First Citizens Bank & Trust Co. now owns 6,930 shares of the specialty chemicals company's stock valued at $234,000 after acquiring an additional 542 shares during the last quarter. Blue Trust Inc. grew its holdings in Olin by 34.3% during the 4th quarter. Blue Trust Inc. now owns 2,887 shares of the specialty chemicals company's stock worth $98,000 after acquiring an additional 738 shares in the last quarter. Finally, Xponance Inc. increased its position in shares of Olin by 5.9% in the 4th quarter. Xponance Inc. now owns 13,435 shares of the specialty chemicals company's stock worth $454,000 after purchasing an additional 754 shares during the last quarter. Institutional investors and hedge funds own 88.67% of the company's stock.

Olin Price Performance

Olin stock traded down $0.24 during midday trading on Friday, hitting $21.99. The company's stock had a trading volume of 1,098,434 shares, compared to its average volume of 1,547,435. Olin Co. has a 12 month low of $17.66 and a 12 month high of $57.10. The company has a quick ratio of 0.77, a current ratio of 1.27 and a debt-to-equity ratio of 1.32. The stock's 50-day moving average price is $23.37 and its 200-day moving average price is $32.56. The company has a market capitalization of $2.53 billion, a PE ratio of 24.43 and a beta of 1.50.

Olin (NYSE:OLN - Get Free Report) last issued its earnings results on Thursday, January 30th. The specialty chemicals company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.10. Olin had a return on equity of 5.10% and a net margin of 1.66%. Analysts anticipate that Olin Co. will post 1.38 earnings per share for the current fiscal year.

Olin Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Thursday, March 6th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.64%. Olin's dividend payout ratio is 88.89%.

Insider Activity

In related news, CEO Kenneth Todd Lane purchased 7,250 shares of the firm's stock in a transaction that occurred on Tuesday, February 4th. The stock was acquired at an average cost of $28.06 per share, for a total transaction of $203,435.00. Following the completion of the acquisition, the chief executive officer now owns 7,250 shares in the company, valued at $203,435. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on OLN shares. Wells Fargo & Company decreased their price target on Olin from $25.00 to $19.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 9th. Bank of America raised Olin from a "neutral" rating to a "buy" rating and dropped their price target for the company from $48.00 to $40.00 in a research report on Tuesday, January 14th. JPMorgan Chase & Co. downgraded shares of Olin from an "overweight" rating to a "neutral" rating and reduced their price target for the stock from $50.00 to $28.00 in a research report on Thursday, February 27th. Citigroup lowered their price objective on shares of Olin from $34.00 to $30.00 and set a "buy" rating for the company in a research report on Thursday, March 27th. Finally, Mizuho set a $23.00 target price on Olin in a research note on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Olin has an average rating of "Hold" and a consensus price target of $33.25.

About Olin

Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.